Turmeric extract may improve irritable bowel syndrome symptomology in otherwise healthy adults: A pilot study

Journal of Alternative and Complementary Medicine

Volumn 10, Issue 6, 2004, Pages 1015-1018

  Bundy, Rafe ^a   Walker, Ann F ^d   Middleton, Richard W ^b   Booth, Jonathan ^c  

^a UNIVERSITY OF READING   (United Kingdom)

^b Lichtwer Pharma UK Ltd   (United Kingdom)

^c ROYAL BERKSHIRE HOSPITAL   (United Kingdom)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ARTICLE; CONTROLLED STUDY; CURCUMA LONGA; CYNARA; FLATULENCE; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; PILOT STUDY; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; SCORING SYSTEM; SELF REPORT; SIDE EFFECT; SYMPTOMATOLOGY; TREATMENT OUTCOME; XEROSTOMIA;

ABDOMINAL PAIN; AGED; CURCUMA; DIARRHEA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; PILOT PROJECTS; PLANT EXTRACTS; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; TIME FACTORS; TREATMENT OUTCOME;

EID: 13144307050     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/acm.2004.10.1015     Document Type: Article

References (14)

1. Barbara G, De Giorgio R, Stanghellini V, Cremon C, Corinaldesi R. A role for inflammation in irritable bowel syndrome? Gut 2002;51(Suppl 1):I41-I44.
2. Bundy R, Walker AF, Middleton RW, Marakis G, Booth JCL. Artichoke leaf extract improves symptoms of irritable bowel syndrome and quality of life in otherwise healthy volunteers suffering concomitant dyspepsia: A subset analysis. J Altern Complement Med 2004;10:667-669.
3. Camilleri M. Dyspepsia, irritable bowel syndrome, and constipation: Review and what's new. Rev Gastroenterol Disord 2001;1:2-17.
4. Drossman DA, ed. ROME II: The Functional Gastrointestinal Disorders, 2nd ed. McLean, VA: Degnon Associates Inc, 1999.
5. El-Serag HB, Olden K, Bjorkman D. Health-related quality of life among persons with irritable bowel syndrome: A systematic review. Aliment Pharmacol Ther 2002;16:1171-1185.
6. Hahn BA, Kirchdoerfer LJ, Fullerton S, Mayer E. Evaluation of a new quality of life questionnaire for patients with irritable bowel syndrome. Aliment Pharmacol Ther 1997;11:547-552.
7. Maxwell PR, Mendall MA, Kumar D. Irritable bowel syndrome. Lancet 1997;350:1691-1695.
8. Mills S, Bone K. Principles and Practice of Phytotherapy. London: Churchill Livingstone, 2000
9. Moher D, Schulz KF, Altman DG. The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001;357:1191-1194.
10. Olden KW. Diagnosis of irritable bowel syndrome. Gastroenterology 2002;122:1701-1714.
11. Pittler MH, Ernst E. Peppermint oil for irritable bowel syndrome: A critical review and metaanalysis. Am J Gastroenterol 1998;93:1131-1135.
12. Surh YJ, Chun KS, Cha HH, Han SS, Keum YS, Park KK, Lee SS. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: Down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat Res 2001;480-481:243-268.
13. Talley NJ, Weaver AL, Zinsmeister AR, Melton LJ, 3rd. Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol 1992;136:165-177.
14. Walker AF, Middleton RW, Petrowicz O. Artichoke leaf extract reduces symptoms of irritable bowel syndrome in a post-marketing surveillance study. Phytother Res 2001;15:58-61.